StockData
PMGC Holdings Inc. logo

PMGC Holdings Inc. (ELAB) stock

ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.47−0.01 (-0.68%)

Close on Nov 18, 2026Market cap $1.31MP/E –Yield –

PMGC revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

PMGC's revenue for the twelve months ending Sep 30, 2026 was $4.82M. For fiscal 2025 it was $590.08K, down 65.5% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$590.08K-65.5%
FY2023Dec 31, 2023$1.71M+123.5%
FY2022Dec 31, 2022$766.28K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.53M+784.9%
Q2 FY2026Jun 30, 2026$1.31M+147.7%
Q1 FY2026Mar 31, 2026$681.99K+12.6%
Q4 FY2025Dec 31, 2025$304.14K-50.5%
Q3 FY2025Sep 30, 2025$285.95K-59.1%
Q3 FY2024Sep 30, 2024$527.48K-4.9%
Q2 FY2024Jun 30, 2024$605.53K+91.3%
Q1 FY2024Mar 31, 2024$614.56K+330.3%
Q4 FY2023Dec 31, 2023$698.59K-99.8%
Q3 FY2023Sep 30, 2023$554.65K–
Q2 FY2023Jun 30, 2023$316.53K–
Q1 FY2023Mar 31, 2023$142.82K–
Q3 FY2022Sep 30, 2022$432.12M–

More PMGC figures

See a number that looks wrong?